| Literature DB >> 30366450 |
Monika E Czerwińska1, Anita Świerczewska2, Sebastian Granica3.
Abstract
The traditional role of Lamium album L. (white dead nettle, Lamiaceae) in providing relief from pain in rheumatism as well as vaginal and cervical inflammation was described. The aim of the study was to screen for the anti-inflammatory bioactivity of compounds isolated from aqueous-methanolic extract of Lamium album herb in human neutrophils (PMNs). The effect of the compounds on the inhibition of selected inflammatory markers released by neutrophils, such as cytokines (IL-8, TNF-α), was studied. The molecular masses and the purity of compounds were determined using high-performance liquid chromatography coupled with diode array detection and mass spectrometry (HPLC-DAD-MSn). The level of cytokines production after incubation with the compounds (1⁻25 µM) was measured by ELISA. Two derivatives of quercetin, not previously described, were isolated in this study. Phenylpropanoids (verbascoside and phlinoside D), as well as iridoids (lamalbid, and shanzhiside methyl ester), and flavonoids revealed to be more significant inhibitors of IL-8 secretion than TNF-α. The compounds at a concentration of 25 µM, except for shanzhiside methyl ester (6), inhibited secretion of IL-8 in the range from 29.1 to 50.0%. In conclusion, L. album might be a valuable source of bioactive compounds and may provide constituents to limit noninfectious inflammation associated with the aforementioned diseases.Entities:
Keywords: Lamiaceae; cytokines; flavonoids; inflammation; iridoids; phenylpropanoids
Mesh:
Substances:
Year: 2018 PMID: 30366450 PMCID: PMC6278331 DOI: 10.3390/molecules23112770
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of isolated compounds.
Figure 2HPLC-chromatograms of isolated compounds recorded at λ = 240 nm. HPLC conditions: Zorbax SB-C18 (150 × 2.1 mm, 1.9 μm), mobile phase: A. 0.1% HCOOH/H2O; linear gradient 0–60 min, 5% to 60% B. 0.1% HCOOH/MeCN.
The spectral data of compounds isolated from the herb of L. album.
| Analyte No. | Compound | UV λmax [nm] | [M − H]−
| Fragmentary Ions |
|---|---|---|---|---|
|
| Apigenin 7- | 269, 317 | 577 | 307, 269 |
|
| Kaempferol 3- | 235sh, 265, 342 | 447 | 327, 285, 255 |
|
| Quercetin 3- | 251, 333 | 785 | 623, 609, 591, 477, 301, 271 |
|
| Verbascoside | 245, 329 | 623 | 461, 315 |
|
| Lamalbid (lamiridoside) | 241 | 467 * | 421, 259 |
|
| Shanzhiside methyl ester | 221 | 451 * | 405, 283, 225, 179, 143 |
|
| Phlinoside D | 216, 328 | 769 | 637, 607, 593, 461 |
|
| Quercetin 3- | 251, 332 | 931 | 887, 785, 769, 755, 738, 702, 609, 562, 490, 301 |
* [M + HCOOH − H]−.
1H and 13C spectral data of compounds 3 and 8 (CD3OD).
| Quercetin | Compound 3 | Compound 8 | ||
|---|---|---|---|---|
| 1H | 13C | 1H | 13C | |
| 2 | - | 159.1 | - | 158.8 |
| 3 | - | 135.3 | - | 134.2 |
| 4 | - | 179.4 | - | 179.4 |
| 4a | - | 105.6 | - | 105.8 |
| 5 | - | 163.1 | - | 163.1 |
| 6 | 6.19 (d, | 99.9 | 6.17 (d, | 99.7 |
| 7 | - | 166.0 | - | 165.6 |
| 8 | 6.33 (d, | 94.8 | 6.30 (d, | 94.6 |
| 8a | - | 158.5 | - | 158.5 |
| 1′ | - | 123.2 | - | 123.3 |
| 2′ | 7.65 (d, | 117.5 | 7.58 (d, | 117.5 |
| 3′ | - | 146.0 | - | 146.1 |
| 4′ | - | 149.7 | - | 149.4 |
| 5′ | 6.92 (d, | 116.1 | 6.94 (d, | 116.1 |
| 6′ | 7.64 (dd, | 123.4 | 7.56 (m) | 123.5 |
|
| ||||
| 1′′ | 5.31 (d, | 103.8 | 5.78 (d, | 100.1 |
| 2′′ | 3.50 (m) | 75.7 | 3.70 (m) | 79.6 |
| 3′′ | 3.45 (m) | 78.1 | 3.58 (m) | 79.1 |
| 4′′ | 3.39 (m) | 71.1 | 3.49 (m) | 71.1 |
| 5′′ | 3.40 (m) | 76.9 | 3.37 (m) | 76.6 |
| 6′′ | 3.85, 3.53 (m) | 68.0 | 3.83, 3.55 (m) | 67.6 |
|
| ||||
| 1′′′ | 4.61 (d, | 102.1 | 4.61 (d, | 101.7 |
| 2′′′ | 3.75 (dd, | 72.2 | 3.75 (m) | 72.2 |
| 3′′′ | 3.80 (dd, | 70.3 | 3.73 (m) | 72.2 |
| 4′′′ | 4.92 (t, | 75.2 | 4.88 (t, | 75.1 |
| 5′′′ | 3.66 (m) | 67.7 | 3.61 (m) | 67.6 |
| 6′′′ | 0.90 (d, | 17.6 | 0.81 (d, | 17.4 |
|
| ||||
| 1′′′′ | 5.24 (d, | 102.3 | ||
| 2′′′′ | 3.98 (dd, | 72.3 | ||
| 3′′′′ | 3.80 (m) | 70.3 | ||
| 4′′′′ | 3.29 (m) | 74.0 | ||
| 5′′′′ | 3.95 (m) | 69.8 | ||
| 6′′′′ | 0.86 (d, | 17.3 | ||
|
| ||||
|
| 6.26 (d, | 116.3 | 6.16 (d, | 116.3 |
|
| 7.56 (d, | 146.8 | 7.53 (d, | 146.8 |
|
| - | 169.0 | - | 169.0 |
| 1′′′′/1′′′′′ | - | 129.9 | - | 129.0 |
| 2′′′′/2′′′′′ | 7.13 (d, | 115.0 | 7.14 (d, | 115.2 |
| 3′′′′/3′′′′′ | - | 147.8 | - | 147.9 |
| 4′′′′/4′′′′′ | - | 151.4 | - | 151.4 |
| 5′′′′/5′′′′′ | 6.98 (d, | 112.5 | 7.00 (d, | 112.6 |
| 6′′′′/6′′′′′ | 7.10 (dd, | 122.9 | 7.12 (dd, | 122.8 |
| OCH3 | 3.90 (s) | 56.3 | 3.92 (s) | 56.4 |
* Carbon numbers of compound 3/# carbon numbers of compound 8.
Figure 3The polymorphonuclear leukocytes (PMNs) viability (%) upon 24 h-treatment with isolated compounds 1–8 and dexamethasone (Dex). Statistical significance was established by ANOVA with Tukey’s post hoc test. * p < 0.001 vs. control cells.
Figure 4Inhibition of IL-8 production (%) by isolated compounds 1–8 in LPS-treated PMNs (mean ± S.E.M.). Dex—dexamethasone. Statistical significance of differences was established by ANOVA with Tukey’s post hoc test. * p < 0.05, ** p < 0.001 vs. (+) LPS; # p < 0.001 vs. (−) LPS; a p < 0.05 vs. a concentration of 25 µM; b p < 0.05 vs. a concentration of 5 µM.
Figure 5Inhibition of TNF-α production (%) by isolated compounds 1–8 in LPS-treated PMNs (mean ± S.E.M.). Dex—dexamethasone. Statistical significance of differences was established by ANOVA with Tukey’s post hoc test. * p < 0.05, ** p < 0.001 vs. (+) LPS; # p < 0.001 vs. (−) LPS; a p < 0.05 vs. a concentration of 25 µM.
Effect of compounds (25 µM) on f-MLP-stimulated ROS generation (mean ± S.E.M. (%)).
| Analyte | ROS Production [%] † |
|---|---|
| (−) f-MLP | 31.3 ± 2.6 |
| (+) f-MLP | 104.5 ± 8.3 # |
| 1 | 42.6 ± 5.1 * |
| 2 | 92.7 ± 6.2 |
| 3 | 16.9 ± 1.2 ** |
| 4 | 42.6 ± 4.2 * |
| 5 | 68.6 ± 5.2 * |
| 6 | 45.7 ± 1.4 * |
| 7 | 21.0 ± 3.4 ** |
| 8 | 10.0 ± 2.6 ** |
| Quercetin | 8.8 ± 1.8 ** |
†% of ROS production compared to (+) f-MLP (100% production); * p < 0.05, ** p < 0.001 vs. stimulated control (control st.), # p < 0.05 vs. control n.st. (Not stimulated control).